Hepatic Carcinoma | Norton Healthcare

Indication: Hepatic Carcinoma

TheraSphere for Treatment of Resected and Unresectable Hepatic Carcinoma

Sub-indication: Hepatic Carcinoma

Device Study - Post Market

Principal Investigator: Robert Martin, M.D., Ph.D.
University of Louisville Physicians - Surgical Oncology

Sponsor: UofL Investigator

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.